Endocrinology, Vol 130, 3633-3640, Copyright © 1992 by Endocrine Society

ARTICLES

Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors

G Mor, Y Amir-Zaltsman, G Barnard and F Kohen
Department of Hormone Research, Weizmann Institute of Science, Rehovot, Israel.

The ability of a monoclonal antiidiotypic antibody (clone 1D5) directed against the binding site of a monoclonal antiestradiol antibody to interact with the estrogen receptor (ER) was investigated. The following lines of evidence indicate that clone 1D5 has the capacity of mimicking the actions of estradiol, and recognizes ER: 1) in binding experiments, clone 1D5 inhibited the binding of [3H]estradiol to porcine cytosolic 32-kilodalton ER fragment in a dose-dependent manner; irrelevant antibody had no effect; 2) in sucrose gradient density analysis, clone 1D5 abolished the specific peak of the [3H] estradiol- ER complex in the 4S region; 3) in immunoprecipitation experiments, clone 1D5 interacted with unoccupied ER, but not with estradiol- occupied ER; 4) in direct immunofluorescence studies clone 1D5 stained the nuclei of cultured rat epithelial cells and recognized estrogen binding sites in nuclear cryostat sections prepared from human, rat, and mouse estrogen-responsive tissues; and 5) When clone 1D5 was injected to immature female rats, it caused 46% increase in uterine creatine kinase activity, suggesting that clone 1D5 may possess estrogenic like activity. Under the same experimental conditions, estradiol caused 58% increase in creatine kinase activity. Collectively, these results suggest that clone 1D5 interacts with the steroid binding site of ER. Therefore, clone 1D5 can serve as a tool in the study of function and structure relationship of ER and to detect changes of ER levels in target cells of various species.

This article has been cited by other articles:

				G. Mor, E. Sapi, V. M. Abrahams, T. Rutherford, J. Song, X.-Y. Hao, S. Muzaffar, and F. Kohen Interaction of the Estrogen Receptors with the Fas Ligand Promoter in Human Monocytes J. Immunol., January 1, 2003; 170(1): 114 - 122. [Abstract] [Full Text] [PDF]

				D. W. Schomberg, J. F. Couse, A. Mukherjee, D. B. Lubahn, M. Sar, K. E. Mayo, and K. S. Korach Targeted Disruption of the Estrogen Receptor-{alpha} Gene in Female Mice: Characterization of Ovarian Responses and Phenotype in the Adult Endocrinology, June 1, 1999; 140(6): 2733 - 2744. [Abstract] [Full Text]

				D. Somjen, F. Kohen, A. Jaffe, Y. Amir-Zaltsman, E. Knoll, and N. Stern Effects of Gonadal Steroids and Their Antagonists on DNA Synthesis in Human Vascular Cells Hypertension, July 1, 1998; 32(1): 39 - 45. [Abstract] [Full Text] [PDF]

				J. Tassignon and F. Haeseleer Abraham Borkowski Natural Antiestrogen Receptor Autoantibodies in Man with Estrogenic Activity in Mammary Carcinoma Cell Culture: Study of their Mechanism of Action; Evidence for Involvement of Estrogen-Like Epitopes J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3464 - 3470. [Abstract] [Full Text] [PDF]